Document 06vkdZpGzBZj5y8dkMkDVXdbO

AR226-3560 er ANDREA V. MALINOWSKI, ESQ. WPhionie:ng(l30o3)Dn7E,4.-619484935 Fax: (302) 741189 VIA OVERNIGHT MAIL UAE 23 September 2005 BeH-05905~ 15555 >4 TSCA Confidential Business Information Center (7407M) AEtPtnA: ESaesctt--ioRno8o(m) 6428 US. Environmental Protection Agency 1201 Constitution Avenue, NW Washington, D.C. 20004-3302 Phone: (202) 564-8940 Dear Sir/Madam: o Yo) NTA No cay ~ IF =36 4 = Re: Perfluorooctansic Acid (PFOA) Plaintiffs' counsel in a case filed against DuPont in West Virginia has provided the following statement in a letter to DuPont: "Please know that C- blood levels are now being returned for Class Members whose blood has been drawn pursuant to the settlement of the C-8 Health Project. Levels are very high, including those found in children. Oneof our lead plaintiff's C-8 levels has almost doubled and is now 276.6. One young child (under age 10) had a C-8 blood level over 600, and both parents had C-8 blood levelsof approximately 500." hPalasinnioftfsv'ercifoiuendsetlhisdiidnfnoortmpartoivoindaentdheDuunPiotnstasdsooecsiantoetd awtietsht tthoetrheepaorctceudravcayloufets.hiDsuPont information. `While DuPont does not believe that the information submitted with this letter triggers reporting obligations under TSCA section 8(), DuPont is forwarding this information to EPA in lightoftheAgency's continued interest in PFOA. [Tr | ie tons Very truly yours, . Lrisree VP Todo cvistoe y Viele Lurene toy